医療セカンドオピニオンの世界市場：洞察、競合情勢、市場予測：2030年

世界の医療セカンドオピニオンの市場規模は、2024年から2030年までの予測期間中に16.79％のCAGRで拡大すると予測されています。医療セカンドオピニオン市場は、がん、感染症、遺伝性疾患、心血管疾患、血液疾患、整形外科疾患などの有病率の世界の高まりにより、大幅な市場成長を遂げています。慢性疾患の有病率の上昇は、世界全体の患者数を増加させ、それによって市場における医療セカンドオピニオンの必要性を生み出しています。さらに、ヘルスケアコストの最適化に対する嗜好の高まり、優れた治療結果の重視の高まり、診断と治療の改善に対するニーズの高まり、患者と医師間のより良い相互作用に対する需要の高まり、仮想医療セカンドオピニオンサービスの開始の増加は、市場における医療セカンドオピニオンの必要性を生み出す見込みです。

世界中で様々ながん、心血管疾患、血液疾患、整形外科疾患、感染症、遺伝性疾患の負担が増加していることが、医療セカンドオピニオン市場を牽引しています。世界保健機関（WHO）2022によると、がんは世界の主要な死因であり、2020年には約1,000万人が死亡します。2020年の乳がんの新規症例は、全世界で226万例でした。同じ情報源によると、肺がんは221万件、結腸・直腸がんは193万件、前立腺がんは141万件、皮膚がんは120万件、胃がんは109万件で、2020年に世界で報告されました。

鎌状赤血球貧血、サラセミアなどの血液疾患の増加も、医療セカンドオピニオン市場にプラスの影響を与えています。例えば、世界保健機関（WHO）の2022年版によると、これらの疾患の重症型を持つ赤ちゃんが世界で毎年30万人以上生まれており、その大半は低・中所得国で生まれていると推定されています。

当レポートでは、世界の医療セカンドオピニオン市場について調査し、市場の概要とともに、疾患タイプ別、サービスプロバイダー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 医療セカンドオピニオン市場レポートのイントロダクション

第2章 医療セカンドオピニオン市場のエグゼクティブサマリー

第3章 医療セカンドオピニオン市場の主な要因分析

• 医療セカンドオピニオン市場の促進要因
• 医療セカンドオピニオン市場の抑制要因と課題
• 医療セカンドオピニオン市場の機会

第4章 医療セカンドオピニオン市場におけるポーターのファイブフォース分析

第5章 医療セカンドオピニオン市場におけるCOVID-19の影響分析

第6章 医療セカンドオピニオン市場の概要

• 疾患タイプ別
• サービスプロバイダー別
• 地域別

第7章 医療セカンドオピニオン市場の企業と製品プロファイル

• Second Opinion International
• EMS
• 2nd.MD
• WorldCare
• MediGuide International, LLC.
• AXA
• Cleveland Clinic.
• USARAD Holdings, Inc., a Nanox company
• London Pain Clinic
• Johns Hopkins University
• Kauvery Hospital
• Yashoda Hospitals.
• Vidal health insurance Tpa Pvt Ltd.
• FOREIGN OPD
• SecondMedic.

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Medical Second Opinion Market
• Table 3: Medical Second Opinion Market Analysis in Global (2021-2030)
• Table 4: Medical Second Opinion Market Analysis in Global by Disorder Type (2021-2030)
• Table 5: Medical Second Opinion Market Analysis in Global by Service Provider (2021-2030)
• Table 6: Medical Second Opinion Market Analysis in Global by Geography (2021-2030)
• Table 7: Medical Second Opinion Market Analysis in North America (2021-2030)
• Table 8: Medical Second Opinion Market Analysis in North America by Country (2021-2030)
• Table 9: Medical Second Opinion Market Analysis in the US (2021-2030)
• Table 10: Medical Second Opinion Market Analysis in Canada (2021-2030)
• Table 11: Medical Second Opinion Market Analysis in Mexico (2021-2030)
• Table 12: Medical Second Opinion Market Analysis in Europe (2021-2030)
• Table 13: Medical Second Opinion Market Analysis in Europe by Country (2021-2030)
• Table 14: Medical Second Opinion Market Analysis in France (2021-2030)
• Table 15: Medical Second Opinion Market Analysis in Germany (2021-2030)
• Table 16: Medical Second Opinion Market Analysis in the UK (2021-2030)
• Table 17: Medical Second Opinion Market Analysis in Italy (2021-2030)
• Table 18: Medical Second Opinion Market Analysis in Spain (2021-2030)
• Table 19: Medical Second Opinion Market Analysis in the Rest of Europe (2021-2030)
• Table 20: Medical Second Opinion Market Analysis in Asia-Pacific (2021-2030)
• Table 21: Medical Second Opinion Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 22: Medical Second Opinion Market Analysis in China (2021-2030)
• Table 23: Medical Second Opinion Market Analysis in Japan (2021-2030)
• Table 24: Medical Second Opinion Market Analysis in India (2021-2030)
• Table 25: Medical Second Opinion Market Analysis in Australia (2021-2030)
• Table 26: Medical Second Opinion Market Analysis in South Korea (2021-2030)
• Table 27: Medical Second Opinion Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Table 28: Medical Second Opinion Market Analysis in the Rest of the World (2021-2030)
• Table 29: Medical Second Opinion Market Analysis in the Rest of the World by Region (2021-2030)
• Table 30: Medical Second Opinion Market Analysis in the Middle East (2021-2030)
• Table 31: Medical Second Opinion Market Analysis in Africa (2021-2030)
• Table 32: Medical Second Opinion Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Medical Second Opinion Market
• Figure 3: Medical Second Opinion Market Analysis in Global (2021-2030)
• Figure 4: Medical Second Opinion Market Analysis in Global by Disorder Type (2021-2030)
• Figure 5: Medical Second Opinion Market Analysis in Global by Service Provider (2021-2030)
• Figure 6: Medical Second Opinion Market Analysis in Global by Geography (2021-2030)
• Figure 7: Medical Second Opinion Market Analysis in North America (2021-2030)
• Figure 8: Medical Second Opinion Market Analysis in North America by Country (2021-2030)
• Figure 9: Medical Second Opinion Market Analysis in the US (2021-2030)
• Figure 10: Medical Second Opinion Market Analysis in Canada (2021-2030)
• Figure 11: Medical Second Opinion Market Analysis in Mexico (2021-2030)
• Figure 12: Medical Second Opinion Market Analysis in Europe (2021-2030)
• Figure 13: Medical Second Opinion Market Analysis in Europe by Country (2021-2030)
• Figure 14: Medical Second Opinion Market Analysis in France (2021-2030)
• Figure 15: Medical Second Opinion Market Analysis in Germany (2021-2030)
• Figure 16: Medical Second Opinion Market Analysis in the UK (2021-2030)
• Figure 17: Medical Second Opinion Market Analysis in Italy (2021-2030)
• Figure 18: Medical Second Opinion Market Analysis in Spain (2021-2030)
• Figure 19: Medical Second Opinion Market Analysis in the Rest of Europe (2021-2030)
• Figure 20: Medical Second Opinion Market Analysis in Asia-Pacific (2021-2030)
• Figure 21: Medical Second Opinion Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 22: Medical Second Opinion Market Analysis in China (2021-2030)
• Figure 23: Medical Second Opinion Market Analysis in Japan (2021-2030)
• Figure 24: Medical Second Opinion Market Analysis in India (2021-2030)
• Figure 25: Medical Second Opinion Market Analysis in Australia (2021-2030)
• Figure 26: Medical Second Opinion Market Analysis in South Korea (2021-2030)
• Figure 27: Medical Second Opinion Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Figure 28: Medical Second Opinion Market Analysis in the Rest of the World (2021-2030)
• Figure 29: Medical Second Opinion Market Analysis in the Rest of the World by Region (2021-2030)
• Figure 30: Medical Second Opinion Market Analysis in the Middle East (2021-2030)
• Figure 31: Medical Second Opinion Market Analysis in Africa (2021-2030)
• Figure 32: Medical Second Opinion Market Analysis in South America (2021-2030)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Market Opportunities
• Figure 36: PORTER's Five Force Analysis

Medical Second Opinion Market By Disorder Type (Organ Transplant, Cardiac Disorder, Hematologic Blood Disorders, Orthopedic Disorders, Cancer, And Others), By Service Provider (Hospitals, Health Insurance Companies, Online Services, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of various chronic diseases across the globe and the surging preference for healthcare cost optimization

The global medical second opinion market is estimated to grow at a CAGR of 16.79% during the forecast period from 2024 to 2030. The medical second opinion market is observing substantial market growth due to the growing prevalence of cancers, infectious diseases, genetic diseases, cardiovascular diseases, hematological diseases, orthopedic diseases, and others across the globe. The increasing prevalence of chronic diseases will increase the overall patient pool across the globe, thereby creating a necessity for a medical second opinion in the market. Furthermore, the surging preference for healthcare cost optimization, the growing emphasis on superior treatment outcomes, the increasing need for improved diagnosis and treatment, the surging demand for better interaction between patients and physicians, and the increasing launches of virtual medical second opinion services, will create a requisite for the medical second opinion in the market. Therefore, the medical second opinion market is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Medical Second Opinion Market Dynamics:

The rising burden of various cancers, cardiovascular disorders, hematologic blood disorders, orthopedic disorders, infectious diseases, and genetic diseases across the globe is driving the medical second opinion market. According to the World Health Organization (WHO) 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The new cases of breast cancer in 2020 were 2.26 million cases, across the globe. The same source stated that lung cancer accounted for 2.21 million new cases, colon and rectum cancer for 1.93 million new cases, prostate cancer with 1.41 million new cases, skin cancer accounted for 1.20 million new cases, and stomach cancer new cases were 1.09 million, reported globally in 2020.

The increasing prevalence of hematological diseases such as sickle cell anemia, thalassemia, and others also affects the market of medical second opinion positively. For instance, according to the World Health Organization (WHO) 2022, it was estimated that each year over 300,000 babies with severe forms of these diseases are born worldwide, the majority in low and middle-income countries.

Thus, the increasing prevalence of cancer across the globe will increase the demand for a medical second opinion as these services are used to obtain additional information that can be useful in improving the disease's treatment outcomes. After a second opinion, the patients may plan their treatment accordingly. Therefore, the rising burden of chronic disease will increase the demand for a medical second opinion.

Moreover, growing healthcare-related expenses will also drive the demand for medical second opinions around the world as it is used as a cost optimization tool. In addition, the second medical opinion market is fueled by a growing emphasis on reducing additional costs and increased awareness about possible exploitation from healthcare organizations, particularly in low- and middle-income countries. Medical second opinions can provide customers with a wealth of information when making important decisions about surgery in the primary case. Furthermore, medical second opinion specialists analyze surgical procedure recommendations based on new medical diagnoses, examination of existing medical data, and evaluation of different therapeutic alternatives to surgery. These characteristics of the second opinion can result in a decrease in the cost of treatment, ultimately increasing the demand for the medical second opinion.

Therefore, the factors stated above collectively will drive the overall medical second opinion market throughout the forecast period from 2024-2030.

However, less awareness about a medical second opinion, higher cost of a medical second opinion, and others may halt the market growth of medical second opinion.

The medical second opinion market was positively impacted during the period of COVID- 19 pandemic. During the initial stage of the pandemic, the demand for physical medical second opinion suffered a loss due to the lesser visit of patients to hospitals or clinics for the treatment or diagnosis of a disease owing to the imposition of strict lockdown rules around the world. However, with the increasing demand for virtual medical second opinions during the pandemic, the demand for the medical second opinion increased exponentially. Patients preferred the virtual mode of medical second opinion service as patients were getting a consultation at their place at their ease and without risking their lives. Likewise, the flexibility in lockdown restrictions, the administration of a vaccine to the public, the resumption of patients to clinics and hospitals second opnion, and with the increasing demand for a virtual medical second opinion, the demand for medical second opinion increased and is expected to grow during the forecast period.

Medical Second Opinion Market Segment Analysis:

Medical Second Opinion Market by Disorder Type (Organ Transplant, Cardiac Disorder, Hematologic Blood Disorders, Orthopedic Disorders, Cancer, and Others), Service Provider (Hospitals, Health Insurance Companies, Online Services, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the disorder type segment of the medical second opinion market, the orthopedic disorder segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the increasing prevalence of various orthopedic diseases such as Arthritis, Osteoarthritis, Rheumatoid Arthritis, Bursitis, Elbow Pain and Problems, Cubital Tunnel Syndrome, Hip Fracture, Low Back Pain, Hand Pain and Problems, Carpal Tunnel Syndrome, and others.

For instance, as per the World Health Organization (WHO) 2022, it was estimated more than 23 million people globally suffered from rheumatoid arthritis in the year 2020 - 2022. As per the same source, it was estimated that by the year 2030, the number of patients suffering from rheumatoid arthritis will get double.

Further, as per the Centers for Disease Control & Prevention (CDC) 2020, around 1.9 million people can get affected by carpal tunnel syndrome, and every year 300,000 to 500,000 surgeries are performed to correct this condition.

Additionally, a recent analysis of Global Burden of Disease (GBD) 2019 data showed that approximately 1.71 billion people globally lived with musculoskeletal conditions, including low back pain, neck pain, fractures, other injuries, osteoarthritis, amputation, and rheumatoid arthritis, in 2019.

Therefore, owing to the increasing prevalence of orthopedic diseases, the demand for orthopedic disease-related medical second opinion services upsurges to get the best possible treatment at an affordable cost, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global medical second opinion market during the forecast period.

North America is expected to dominate the overall Medical Second Opinion Market:

Among all the regions, North America is expected to dominate the global medical second opinion in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the increasing demand for medical second opinions among the patients in the region owing to the increasing prevalence of various diseases such as cancers, cardiovascular, diabetes, infectious, and others. The rising burden of geriatric patients prone to chronic diseases, increasing demand for a virtual medical second opinion, and others are among the key factors that contribute to the growth of the medical second opinion market in North America during the forecast period from 2022 - 2028.

For instance, according to GLOBOCAN 2022, the total number of new cancer cases was 2,281,658 in the United States, in 2020. The rising cases of cancers will increase the demand for medical second opinions these services are used to obtain additional information that can be useful in improving the disease's treatment outcomes at an affordable cost.

Additionally, the presence of various insurance providers who is covering the second opinion service in the portfolio in North America will also propel the demand for a medical second opinion. Also, owing to the presence of advanced healthcare infrastructure and a well-informed patient base.

Several organizations in the region assist patients with second views, such as WorldCare International Inc., which connects members with doctors to examine treatment plans, confirm diagnoses, answer questions, and provide prompt second opinions.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the medical second opinion market.

Medical Second Opinion Market Key Players:

Some of the key market players operating in the medical second opinion market include Second Opinion International, EMS, 2nd.MD, WorldCare, MediGuide International, LLC., AXA, Cleveland Clinic., USARAD Holdings, Inc., a Nanox company, London Pain Clinic, Johns Hopkins University, Kauvery Hospital, Yashoda Hospitals., Vidal health insurance tpa pvt ltd., FOREIGN OPD, SecondMedic., and others.

Recent Developmental Activities in the Medical Second Opinion Market:

In January 2022, Apollo Hospitals Group collaborated with "The Clinic" by Cleveland Clinic, to bring international second opinion services to their patients.

In January 2022, Accolade, a startup that helps patients navigate their health benefits, plans to acquire the second medical opinion platform 2nd.MD for $460 million.

In August 2020, ConsumerMedical acquired a virtual second opinion innovator. This acquisition streamlines the delivery of critical, expert medical guidance which gives participants facing serious and complex illnesses a more convenient, tech-enabled, and virtual experience.

Key Takeaways from the Medical Second Opinion Market Report Study

Market size analysis for current medical second opinion market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the medical second opinion market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global medical second opinion market.

Various opportunities available for the other competitor in the medical second opinion market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current medical second opinion market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for medical second opinion market growth in the coming future?

Target Audience who can be benefited from this Medical Second Opinion Market Report Study

Medical second opinion service providers

Research organizations and consulting companies

Medical second opinion-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in the medical second opinion

Various end users who want to know more about the medical second opinion market and the latest developments in the medical second opinion market.

Frequently Asked Questions for the Medical Second Opinion Market:

1. What is a medical second opinion?

The medical second opinion, is a type of service that provide additional consultation, taken by the patient after the primary diagnosis. The patient can go for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures.

2. What is the global market for the medical second opinion?

The global medical second opinion market is estimated to grow at a CAGR of 16.79% during the forecast period from 2024 to 2030.

3. What are the drivers for the global medical second opinion market?

The medical second opinion market is witnessing positive market growth owing to the factors such as the growing incidence of chronic diseases, the surging preference for healthcare cost optimization, growing emphasis on superior treatment outcomes, the increasing need for improved diagnosis and treatment, surging availability and demand of virtual medical second opinion especially after the pandemic, presence of key players in the market, and others will create an exigency for the medical second opinion market.

4. Who are the key players operating in the global medical second opinion market?

Some of the key market players operating in the medical second opinion market include Second Opinion International, EMS, 2nd.MD, WorldCare, MediGuide International, LLC., AXA, Cleveland Clinic., USARAD Holdings, Inc., a Nanox company, London Pain Clinic, Johns Hopkins University, Kauvery Hospital, Yashoda Hospitals., Vidal health insurance tpa pvt ltd., FOREIGN OPD, SecondMedic., and others.

5. Which region has the highest share of the medical second opinion market?

Among all the regions, North America is estimated to hold a significant revenue share in the global medical second opinion market. This can be ascribed to the increasing demand for medical second opinion among the patients in the region owing to the increasing prevalence of various diseases such as cancers, cardiovascular, diabetes, infectious, and others. Further, the rising burden of geriatric patients prone to chronic diseases, increasing demand for a virtual medical second opinion, and the presence of key domicile players in the region are the reasons which act as a supportive factor for the North America medical second opinion market growth.

Table of Contents

1.Medical Second Opinion Market Report Introduction

2. Medical Second Opinion Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Medical Second Opinion Market Key Factors Analysis

• 3.1. Medical Second Opinion Market Drivers
  • 3.1.1. Growing incidence of chronic diseases
  • 3.1.2. The surging preference for healthcare cost optimization
  • 3.1.3. Growing emphasis on superior treatment outcomes
  • 3.1.4. The increasing need for improved diagnosis and treatment
• 3.2. Medical Second Opinion Market Restraints and Challenges
  • 3.2.1. Less awareness about the medical second opinion
  • 3.2.2. Higher cost of the medical second opinion
• 3.3. Medical Second Opinion Market Opportunities
  • 3.3.1. Increasing investments in telehealth technologies owing to the surging demand for virtual medical second opinion across the globe
  • 3.3.2. Rising modernization and technological advancements in the healthcare sector

4. Medical Second Opinion Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

5. COVID-19 Impact Analysis on Medical Second Opinion Market

6. Medical Second Opinion Market Layout

• 6.1. By Disorder Type
  • 6.1.1. Organ Transplant
  • 6.1.2. Cardiac Disorder
  • 6.1.3. Hematologic Blood Disorders
  • 6.1.4. Orthopedic Disorders
  • 6.1.5. Others.
• 6.2. By Service Provider
  • 6.2.1. Hospitals
  • 6.2.2. Health Insurance Companies
  • 6.2.3. Online Services
  • 6.2.4. Others
• 6.3. By Geography
  • 6.3.1. North America
    • 6.3.1.1. United States Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.1.2. Canada Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.1.3. Mexico Medical Second Opinion Market in USD million (2021-2030)
  • 6.3.2. Europe
    • 6.3.2.1. France Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.2.2. Germany Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.2.3. United Kingdom Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.2.4. Italy Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.2.5. Spain Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.2.6. Rest of Europe Medical Second Opinion Market in USD million (2021-2030)
  • 6.3.3. Asia-Pacific
    • 6.3.3.1. China Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.3.2. Japan Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.3.3. India Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.3.4. Australia Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.3.5. South Korea Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.3.6. Rest of Asia Pacific Medical Second Opinion Market in USD million (2021-2030)
  • 6.3.4. Rest of the World (RoW)
    • 6.3.4.1. Middle East Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.4.2. Africa Medical Second Opinion Market in USD million (2021-2030)
    • 6.3.4.3. South America Medical Second Opinion Market in USD million (2021-2030)

7. Medical Second Opinion Market Company and Product Profiles

• 7.1. Second Opinion International
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. EMS
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. 2nd.MD
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. WorldCare
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. MediGuide International, LLC.
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. AXA
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Cleveland Clinic.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. USARAD Holdings, Inc., a Nanox company
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. London Pain Clinic
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Johns Hopkins University
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Kauvery Hospital
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Yashoda Hospitals.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Vidal health insurance Tpa Pvt Ltd.
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. FOREIGN OPD
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. SecondMedic.
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us